Table 1.

Selected radiobiological parameters for tumor calculations (gEUD and TCP). Values were obtained from AAPM TG‐166 report, Cheung, ⁵⁴ , ⁵⁵ King, ⁽⁵⁶⁾ Okunieff, ⁽⁴⁵⁾ and Levegrun ⁽⁵⁷⁾ studies

			Parameters
			a	$\alpha \hspace{0.17em}(G{y}^{-1})$	$\alpha /\beta \hspace{0.17em}(Gy)$	$D_{50}(Gy)$	${\gamma }_{50}(\%/\%)$
TG‐166	BPhant	PTVRect	‐10	0.1	10	63.3	5
		Rect1	$-10$	0.1	10	44.2	1.6
	H&N	PTV 70	$-10$	0.1	10	51.77	2.28
		PTV54	$-10$	0.1	10	51.77	2.28
		PTV50	$-10$	0.1	10	51.77	2.28
	Prostate	PTV70.2	$-10$	0.1	3	46.29	0.95
	Brain	GTV54	$-10$	0.1	10	22.17	0.70
		PTV50.4	$-10$	0.1	10	22.17	0.70
Analyzed prostate cases	Cheung and King studies	HR PTV	$-10$	0.1	1.5	75.5	1.7
		IR PTV	$-10$	0.1	1.5	67.5	2.2
		LR PTV	$-10$	0.1	1.5	57.3	1.4
		Bed PTV	$-10$	0.1	1.5	66.8	2.54
	Okunieff	All staging	$-10$	0.1	1.5	46.29	0.95
	Levegrun	PTV	$-10$	0.1	1.5	70.5	2.9

$\text{BPhant}=\text{benchmark phantom}$; $\text{PTVRect}=\text{PTV Rectangle}$; $\text{Rect}1=\text{Rectangle} 1$; $\mathrm{H}\&\mathrm{N}=\text{head and neck}$; $\text{HR}=\text{high}-\text{risk}$; $\text{IR}=\text{intermediate}-\text{risk}$; $\text{LR}=\text{low}-\text{risk}$.